1Picardo M, TaYeb A. Vitiligo. Berlin Heidelberg: Springer-Verlag, 2010: 13-24.
2Koga M, Tango T. Clinical features and course of type A and type B vitiligo. Br J Dermatol, 1988, 118(2): 223-228.
3Ezzedine K, Gauthier Y, L6aut6-Labr-ze C, et al. Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients. J Am Acad Dermatol, 2011, 65(5): 965-971.
4van Geel NA, Mollet IG, De Schepper S, et al. First histopatho- logical and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi. Pigment Cell Melanoma Res, 2010, 23(3): 375-384.
5TaYeb A, Morice-Picard F, Jouary T, et al. Segmental vitiligo asthe possible expression of cutaneous somatic mosaicism: implica- tions for common non-segmental vitiligo. Pigment Cell Melanoma Res, 2008, 21(6): 646-652.
6Mulekar SV, A1 Issa A, Asaad M, et al. Mixed vitiligo. J Cutan Med Surg, 2006, 10(2): 104-107.
7Falabel|a R, Escobar CE, Carrascal E, et al. Leukoderma punctata. J Am Acad Dermatol, 1988, 18(3): 485-494.
8Boissy RE, Manga P. On the etiology of contact/occupational vitiligo. Pigment Cell Res, 2004, 17(3): 208-214.
9Le Poole IC, Luiten RM. Autoimmune etiology of generalized vitiligo. Curr Dir Autoimmun, 2008, 10: 227-243.
10Spritz RA. Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis. J Invest Derrnatol, 2012, 132(2): 268-273.
